image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates

Quantum Pharma - Eps enhancing deal

August 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • QP
  • Price:
  • 155p
Quantum has acquired NuPharm for £9.3m cash with a further £4m based on future performance. Based in North Wales, NuPharm is an outsourced manufacturer for solid and liquid dose batch-made specials and niche licensed pharmaceutical products. It makes 90+ of the most commonly prescribed (non-sterile) specials and consequently brings in house a previously sub-contracted activity and nicely complements Quantum’s mainstay, which is single, bespoke formulations that are made-to-order.  NuPharm has a number of products in co-development with customers. It also holds three UK patents in relation to foam formulations or sprays and pending UK/US patents in relation to liquid dosage forms and delivery systems.In ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW